Skip to content

The effect of metformin in different phenotypes of poly cystic ovary syndrome according to Rotterdam criteria criteria

The effect of metformin in different phenotypes of poly cystic ovary syndrome according to Rotterdam criteria criteria

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201103146063N1
Enrollment
290
Registered
2011-06-02
Start date
2010-07-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poly cystic ovary syndrome. PCOD ( poly cystic ovary syndrome)

Interventions

Intervention 1: Intervention: metformin tablet 500 mg TDS from two months before starting ovulation induction, then ovulation induction started on day 2-6 of menstrual cycle with Letrozole 2.5 mg twic
Treatment - Drugs
Intervention: metformin tablet 500 mg TDS from two months before starting ovulation induction, then ovulation induction started on day 2-6 of menstrual cycle with Letrozole 2.5 mg twice per day, when
In control groups: no drug used before starting ovulation induction, then ovulation induction started on day 2-6 of menstrual cycle with Letrozole tablet 2.5 mg twice per day, when dominant follicle

Sponsors

Tehran University of Medical Science and Health Service
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Infertile women were included in the patients attending the outpatient clinic of the Infertility Research Centre of Shariati Hospital. The diagnosis of PCOD was based on the Rotterdam criteria, age between 18 to35 years, normal thyroid, liver and kidney, normal sperm count according to WHO criteria, taking no metformin in previous 8 weeks, normal hysterosalpingography Exclusion criteria: mullerian anomaly, abnormal sperm count, thyroid, liver or kidney dysfunction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate. Timepoint: three months and half after starting the treatment. Method of measurement: trans vaginal sonography.;Ovulation rate. Timepoint: two months and half after starting the treatment. Method of measurement: transvaginal sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Sarvi

Tehran University of Medical Science and Health Service, Shariati Hospital

fsarvi@razi.tums.ac.ir sarvi.fateme@yahoo.com+98 21 8800 8810

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026